Carglumic acid is an orphan drug that is utilized for treatment of patients with hyperammonemia, which implies deficiency of N-acetylglutamate (NAG) synthase. Well known as N-carbamoyl-L-glutamic acid (NCGA) or Carbaglu, carglumic acid stimulates the initial enzyme in urea cycle, which helps in detoxification and removal of ammonia from blood cells. Carglumic acid is on the verge of becoming an indispensable therapeutic tool for managing life-threating & rare inborn metabolic disorders that affect the urea cycle.
Carglumic Acid holds Potential in Accelerating Cancer Cell Suppression and Promoting Apoptosis
Analysis of in vivo models have showcased carglumic acid to stimulate liver carbamoyl phosphate synthetase. Although carbamoyl phosphate synthetase has a relatively lower affinity for carglumic acid than N-acetylglutamate (NAG), carglumic acid has been represented in vitro to activate carbamoyl phosphate synthetase, being much more effective in preventing ammonia intoxication. This orphan drug is currently gaining huge traction in treating patients with hyperammonemia, a rare congenital disorder caused by genetic defects pertaining to urea cycle enzymes. Carglumic acid also holds potential in accelerating cancer cell suppression, thereby promoting apoptosis in various types of cancers such as lung cancer and pancreatic ductal adenocarcinoma. These Factors will determine the future expansion of the market for carglumic acid across the globe.
Researchers across the globe are working on the development of “whole exome sequencing” procedure, with an aim of preventing intellectual disability in children through the combination of metabolomics analysis of carglumic acid and genome sequencing. Carglumic acid is further being utilized for application in enhancing ammonia detoxification in patients with organic acidurias. Transparency Market Research’s new report states that the global carglumic acid market will reflect an impressive expansion through the forecast period (2017-2026). Worldwide sales of carglumic acid is estimated to reach revenues worth nearly US$ 190 Mn by 2026-end.
North America to Remain Dominant in Global Carglumic Acid Market
North America will continue to dominate the global carglumic acid market, accounting for more than one-third market revenue share during the forecast period. Carglumic acid has gained significant traction among North American healthcare professionals for treating hyperammonemia. Researchers in the region are focusing on adjunctive treatment and maintenance therapy associated with acute hyperammonemia and chronic hyperammonemia, which are caused by deficiency of N-acetylglutamate synthase (NAGS) in elder population and pediatric patients. Regulatory bodies and pharmaceutical companies in the region are also focusing on patient education concerned with dosage and use of carglumic acid, so as to prevent patients from any side effects.
Tablet for suspension is anticipated to remain the most lucrative delivery format of carglumic acid, with sales estimated to exceed US$ 100 Mn by 2026-end. This delivery format of carglumic acid will witness a robust expansion in sales through 2026. In addition, sales of carglumic acid in the delivery format of orally disintegrating tablets will exhibit an impressive expansion through 2026.
Although hospital pharmacies are expected to remain the largest distribution channels for carglumic acid, sales in e-commerce is likely to witness a relatively faster expansion through 2026. Retail pharmacies will witness a comparatively faster expansion than hospital pharmacies in the market, however market revenue share of the former will remain relatively lower than the latter throughout the forecast period.
Competition Landscape
The global market for carglumic acid is dominated by few well-established players, who are continuously working on developing new formulations for carglumic acid. This has further created challenges for new market entrants in terms of product differentiation and quality. Key players profiled by TMR’s report include Recordati S.p.A, Civentichem LLC, and Dipharma Francis S.r.l. These players are continuous working on developing new formulations of carglumic acid to stay at the market’s forefront. For example – Dipharma, s Swiss pharmaceutical company, has recently announced its development of new & fast-dissolving formulation of the carglumic acid tablets, which remain stable at room temperature. In addition, Recordati S.p.A has announced inclusion of its Canadian affiliate, named Recordati Rare Diseases Canada Inc, thereby expanding its market presence.
Carglumic Acid Market to Attain Significant Revenues Owing to Advancement of Exome Sequencing System
The interest inside the worldwide market for carglumic acid has been ascending by virtue of headways in the drug business. Carglumic acid is utilized to fabricate a few types of remedial tablets, and this is a critical point of view from the viewpoint of market development. The main merchants in the worldwide carglumic acid market have set on a binge to tie up with new selling focuses for this acid. This system won't simply acquire a more noteworthy piece of the pie for the players, however will likewise get humongous incomes into their kitty. The worldwide carglumic acid market is relied upon to go through progressive fracture as a few more modest merchants go under the spotlight of consideration.
There is a high chance of medical services elements putting resources into the worldwide carglumic acid market in the years to come. This pattern will clear route for the inflow of expanded incomes into business of little and enormous merchants in the worldwide carglumic acid market. The medium-sized parts in the worldwide carglumic acid market are relied upon to converge in with the bigger and set up players. Scientists across the globe are chipping away at the advancement of "entire exome sequencing" system, with a point of forestalling scholarly handicap in kids through the mix of metabolomics investigation of carglumic acid and genome sequencing. Carglumic acid is further being used for application in upgrading alkali detoxification in patients with natural acidurias.
The main considerations crediting to the development of the carglumic acid market are the ascent in liquor utilization, smoking and inactive life prompting different tumors alongside with the worldwide pervasiveness of metabolic issues like hepatic encephalopathy, Reye's disorder, cirrhosis. In this manner, bringing about abundance levels of smelling salts in the blood, resultant more appeal for treatment. Additionally, carglumic acid has likewise shown potential for against tumor action in bosom malignant growth, alongside different applications in makeup, and synthetics which are relied upon to fuel the worldwide carglumic acid market during the estimate time frame.
Market Taxonomy
Moving further the report propounds analysis on global market for carglumic acid with the help of a segmentation analysis. Global market for carglumic acid is divided into three key segments, which are distribution channel, delivery format, and region. Revenue comparison and Y-o-Y growth comparison, in addition to market share comparison of these segments are contained in the report, for offering most significant market numbers appertaining to the segmentation analysis. The global carglumic acid market has been characterized regionally into six key segments namely, Asia-Pacific excluding Japan (APEJ), Latin America, North America, Europe, Japan, and Middle East & Africa (MEA).
|
Region |
|
|
Delivery Format |
|
|
Distribution Channel |
|
Chapter 1 Global Outlook
1.1 Global Healthcare Sector Outlook
Chapter 2 Global Carglumic Acid Market - Executive Summary
Chapter 3 Global Carglumic Acid Market Overview
3.1 Introduction
3.1.1 Global Carglumic Acid Market Taxonomy
3.1.2 Global Carglumic Acid Market Definition
3.2 Global Carglumic Acid Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1 Global Carglumic Acid Market Y-o-Y Growth
3.3 Global Carglumic Acid Market Dynamics
3.4 Supply Chain
3.5 Cost Structure
3.6 Pricing Analysis
3.7 Reimbursement Scenario
3.8 Carglumic Acid Indication and Usage
3.9 Dosage and Administration of Carglumic Acid
3.10 Use of Carglumic Acid in Specific Population
3.11 Key Regulations
3.11.1 North America Key Regulations
3.11.2 Latin America Key Regulations
3.11.3 Europe – Key Regulations
3.11.4 APEJ – Key Regulations
3.11.5 MEA – Key Regulations
3.12 PEST Analysis
3.13 Drug Pipeline Assessment
3.14 Clinical Trials on Carglumic Study
3.15 List of Distributors
Chapter 4 Global Carglumic Acid Market Analysis and Forecast 2012-2026
4.1 Global Carglumic Acid Market Size and Forecast By Delivery Format, 2012-2026
4.1.1 Tablet, orally disintegrating Market Size and Forecast, 2012-2026
4.1.1.1 Revenue (US$ Mn) Comparison, By Region
4.1.1.2 Market Share Comparison, By Region
4.1.1.3 Y-o-Y growth Comparison, By Region
4.1.2 Tablet, for suspension Market Size and Forecast, 2012-2026
4.1.2.1 Revenue (US$ Mn) Comparison, By Region
4.1.2.2 Market Share Comparison, By Region
4.1.2.3 Y-o-Y growth Comparison, By Region
4.2 Global Carglumic Acid Market Size and Forecast By Distribution Channel, 2012-2026
4.2.1 Hospital Pharmacies Market Size and Forecast, 2012-2026
4.2.1.1 Revenue (US$ Mn) Comparison, By Region
4.2.1.2 Market Share Comparison, By Region
4.2.1.3 Y-o-Y growth Comparison, By Region
4.2.2 Retail Pharmacies Market Size and Forecast, 2012-2026
4.2.2.1 Revenue (US$ Mn) Comparison, By Region
4.2.2.2 Market Share Comparison, By Region
4.2.2.3 Y-o-Y growth Comparison, By Region
4.2.3 E-Commerce Market Size and Forecast, 2012-2026
4.2.3.1 Revenue (US$ Mn) Comparison, By Region
4.2.3.2 Market Share Comparison, By Region
4.2.3.3 Y-o-Y growth Comparison, By Region
Chapter 5 North America Carglumic Acid Market Size and Forecast, 2012-2026
5.1 North America Market Outlook
5.1.1 Political Outlook
5.1.2 Economic Outlook
5.1.3 Business Environment Outlook
5.1.4 North America Healthcare Sector Outlook: Will the Obama Care Senate Repeal Bill Thrash Federal Medicaid Healthcare Funding?
5.1.5 North America Carglumic Acid Market Overlook:
5.2 Revenue (US$ Mn) Comparison, By Country
5.3 Revenue (US$ Mn) Comparison, By Delivery Format
5.4 Revenue (US$ Mn) Comparison, By Distribution Channel
Chapter 6 Latin America Carglumic Acid Market Size and Forecast, 2012-2026
6.1 Latin America Market Outlook
6.1.1 Political Outlook
6.1.2 Economic Outlook
6.1.3 Business Environment Outlook
6.1.4 Latin America Healthcare Sector Outlook: Growing Public-Private Partnerships are augmenting the Provision of Basic Healthcare Services
6.1.5 Latin America Carglumic Acid Market Outlook:
6.2 Revenue (US$ Mn) Comparison, By Country
6.3 Revenue (US$ Mn) Comparison, By Delivery Format
6.4 Revenue (US$ Mn) Comparison, By Distribution Channel
Chapter 7 Europe Carglumic Acid Market Size and Forecast, 2012-2026
7.1 Europe Market Outlook
7.1.1 Political Outlook
7.1.2 Economic Outlook
7.1.3 Business Environment Outlook
7.1.4 Europe Healthcare Sector Outlook
7.1.5 Europe Carglumic Acid Market Outlook
7.2 Revenue (US$ Mn) Comparison, By Country
7.3 Revenue (US$ Mn) Comparison, By Delivery Format
7.4 Revenue (US$ Mn) Comparison, By Distribution Channel
Chapter 8 Japan Carglumic Acid Market Size and Forecast, 2012-2026
8.1 Japan Market Outlook
8.1.1 Political Outlook
8.1.2 Economic Outlook
8.1.3 Business Environment Outlook
8.1.4 Japan Healthcare Sector Outlook: Generics Will Continue to Create New Opportunities, While the Overall Environment Remains Conducive for Innovation in Clinical Trials and Biotech
8.1.5 Japan Carglumic Acid Market Outlook:
8.2 Revenue (US$ Mn) Comparison, By Country
8.3 Revenue (US$ Mn) Comparison, By Delivery Format
8.4 Revenue (US$ Mn) Comparison, By Distribution Channel
Chapter 9 APEJ Carglumic Acid Market Size and Forecast, 2012-2026
9.1 APEJ Market Outlook
9.1.1 Political Outlook
9.1.2 Economic Outlook
9.1.3 Business Environment Outlook
9.1.4 Asia Pacific Excluding Japan (APEJ) Healthcare Sector Outlook9.1.5 Asia Pacific Excluding Japan (APEJ) Carglumic Acid Market Outlook:
9.2 Revenue (US$ Mn) Comparison, By Country
9.3 Revenue (US$ Mn) Comparison, By Delivery Format
9.4 Revenue (US$ Mn) Comparison, By Distribution Channel
Chapter 10 MEA Carglumic Acid Market Size and Forecast, 2012-2026
10.1 MEA Market Outlook
10.1.1 Political Outlook
10.1.2 Economic Outlook
10.1.3 Business Environment Outlook
10.1.4 Middle East & Africa (MEA) Healthcare Sector Outlook
10.1.5 Middle East & Africa (MEA) Carglumic Acid Market Outlook
10.2 Revenue (US$ Mn) Comparison, By Country
10.3 Revenue (US$ Mn) Comparison, By Delivery Format
10.4 Revenue (US$ Mn) Comparison, By Distribution Channel
Chapter 11 Global Carglumic Acid Market Company Profiles
11.1 Recordati S.p.A.
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Key Financials
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Civentichem, LLC
11.2.1 Company Overview
11.2.2 Product Overview
11.3 Dipharma Francis S.r.l.
11.3.1 Company Overview
11.3.2 Product Overview
11.4 Key Takeaways of Carglumic Acid Market
Chapter 12 TMR Research Methodology
Chapter 13 Disclaimer and Contact information
List of Tables
TABLE 1 Global Carglumic Acid Market Value (US$ Mn), 2012-2017
TABLE 2 Global Carglumic Acid Market Value (US$ Mn), 2018-2026
TABLE 3 Global Carglumic Acid Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Tablet, orally disintegrating Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Tablet, orally disintegrating Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Tablet, orally disintegrating Segment Market Share, By Region 2012-2017
TABLE 7 Global Tablet, orally disintegrating Segment Market Share, By Region 2018-2026
TABLE 8 Global Tablet, orally disintegrating Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Tablet, for suspension Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Tablet, for suspension Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Tablet, for suspension Segment Market Share, By Region 2012-2017
TABLE 12 Global Tablet, for suspension Segment Market Share, By Region 2018-2026
TABLE 13 Global Tablet, for suspension Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
TABLE 17 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
TABLE 18 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Retail Pharmacies Segment Market Share, By Region 2012-2017
TABLE 22 Global Retail Pharmacies Segment Market Share, By Region 2018-2026
TABLE 23 Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global E-Commerce Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global E-Commerce Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global E-Commerce Segment Market Share, By Region 2012-2017
TABLE 27 Global E-Commerce Segment Market Share, By Region 2018-2026
TABLE 28 Global E-Commerce Segment Y-o-Y, By Region 2017-2026
TABLE 29 North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 30 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 31 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 32 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 33 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 34 North America Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
TABLE 35 North America Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
TABLE 36 North America Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
TABLE 37 North America Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
TABLE 38 North America Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 39 North America Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 40 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 41 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 42 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 43 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 44 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 45 Latin America Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
TABLE 46 Latin America Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
TABLE 47 Latin America Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
TABLE 48 Latin America Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
TABLE 49 Latin America Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 50 Latin America Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 51 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 52 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 53 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 54 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 55 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 56 Europe Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
TABLE 57 Europe Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
TABLE 58 Europe Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
TABLE 59 Europe Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
TABLE 60 Europe Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 61 Europe Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 62 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 63 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 64 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 65 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 66 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 67 Japan Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
TABLE 68 Japan Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
TABLE 69 Japan Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
TABLE 70 Japan Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
TABLE 71 Japan Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 72 Japan Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 73 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 74 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 75 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 76 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 77 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 78 APEJ Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
TABLE 79 APEJ Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
TABLE 80 APEJ Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
TABLE 81 APEJ Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
TABLE 82 APEJ Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 83 APEJ Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 84 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 85 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 86 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 87 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 88 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 89 MEA Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
TABLE 90 MEA Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
TABLE 91 MEA Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
TABLE 92 MEA Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
TABLE 93 MEA Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 94 MEA Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
List of Figures
FIG. 1 Global Carglumic Acid Market Value (US$ Mn), 2012-2017
FIG. 2 Global Carglumic Acid Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Carglumic Acid Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global Tablet, orally disintegrating Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global Tablet, orally disintegrating Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global Tablet, orally disintegrating Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Tablet, for suspension Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Tablet, for suspension Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Tablet, for suspension Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global E-Commerce Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global E-Commerce Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global E-Commerce Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 North America Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
FIG. 20 North America Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
FIG. 21 North America Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
FIG. 22 North America Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
FIG. 23 North America Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 24 North America Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 25 Latin America Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
FIG. 26 Latin America Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
FIG. 27 Latin America Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
FIG. 28 Latin America Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
FIG. 29 Latin America Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 30 Latin America Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 31 Europe Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
FIG. 32 Europe Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
FIG. 33 Europe Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
FIG. 34 Europe Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
FIG. 35 Europe Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 36 Europe Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 37 Japan Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
FIG. 38 Japan Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
FIG. 39 Japan Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
FIG. 40 Japan Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
FIG. 41 Japan Carglumic Acid Market Value (US$ Mn), By 2012-2017
FIG. 42 Japan Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 43 APEJ Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
FIG. 44 APEJ Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
FIG. 45 APEJ Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
FIG. 46 APEJ Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
FIG. 47 APEJ Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 48 APEJ Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 49 MEA Carglumic Acid Market Value (US$ Mn), By Country 2012-2017
FIG. 50 MEA Carglumic Acid Market Value (US$ Mn), By Country 2018-2026
FIG. 51 MEA Carglumic Acid Market Value (US$ Mn), By Delivery Format 2012-2017
FIG. 52 MEA Carglumic Acid Market Value (US$ Mn), By Delivery Format 2018-2026
FIG. 53 MEA Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 54 MEA Carglumic Acid Market Value (US$ Mn), By Distribution Channel 2018-2026
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Carglumic Acid Market
